T0	Participants 129 170	patients with early rheumatoid arthritis:
T1	Participants 287 312	rheumatoid arthritis (RA)
T2	Participants 486 620	patients with early RA initially treated with a combination of three disease-modifying antirheumatic drugs (DMARDs) or a single DMARD.
T3	Participants 641 674	199 patients with early active RA
T4	Participants 1782 1794	RA patients.